Safety-focused medication therapy management: A randomized controlled trial

Journal of the American Pharmacists Association

Volumn 52, Issue 5, 2012, Pages 603-612

  Touchette, Daniel R ^a   Masica, Andrew L ^b   Dolor, Rowena J ^c   Schumock, Glen T ^a   Choi, Young Ku ^a   Kim, Yoonsang ^d   Smith, Scott R ^e  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b BAYLOR HEALTH CARE SYSTEM   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

Medicare; Medication adherence; Medication errors; Medication therapy management; Medication related problems; Pharmacists

Indexed keywords

PRESCRIPTION DRUG; DRUG;

ADVERSE DRUG REACTION; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION ALGORITHM; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; FAMILY MEDICINE; FEMALE; HEALTH CARE; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; MULTICENTER STUDY; PATIENT CARE; PATIENT EDUCATION; PATIENT SAFETY; PHARMACIST; PHARMACY; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; UNITED STATES; UNSPECIFIED SIDE EFFECT; CONTROLLED CLINICAL TRIAL; HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; STATISTICS; UNIVERSITY HOSPITAL; UTILIZATION REVIEW;

ACADEMIC MEDICAL CENTERS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HEALTH SERVICES; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; PHARMACEUTICAL PREPARATIONS;

EID: 84874401402     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.12036     Document Type: Article

References (34)

1. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140:714-20.
2. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337-44.
3. Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867-78.
4. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood). 2007;26:1735-44.
5. Schneeweiss S, Patrick AR, Pedan A, et al. The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood). 2009;28:w305-16.
6. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-16.
7. Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19:901-10.
8. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155:1949-56.
9. Public Law 108-173. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Accessed at www.cms.gov/CCIP/downloads/section-721. pdf, June 12, 2010.
10. Smith SR, Clancy CM. Medication therapy management programs: forming a new cornerstone for quality and safety in Medicare. Am J Med Qual. 2006;21:276-9.
11. McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc. 2007;47:620-8.
12. Touchette DR, Burns AL, Bough MA, Blackburn JC. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc. 2006;46:683-91.
13. Boyd ST, Boyd LC, Zillich AJ. Medication therapy management survey of the prescription drug plans. J Am Pharm Assoc. 2006;46:692-9.
14. Pellegrino AN, Martin MT, Tilton JJ, Touchette DR. Medication therapy management services: definitions and outcomes. Drugs. 2009;69:393-406.
15. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care. 1991;29:989-1003.
16. van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859-67.
17. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795-801.
18. Masica AL, Touchette DR, Dolor RJ, et al. Evaluation of a medication therapy management program in Medicare beneficiaries at high risk of adverse drug events: study methods (vol. 4: technology and medication safety). Rockville, MD: Agency for Healthcare Research and Quality; 2008.
19. Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53:318-25.
20. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.
21. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27:1104-11.
22. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203-11.
23. Lee AJ, Boro MS, Knapp KK, et al. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health Syst Pharm. 2002;59:2070-7.
24. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652-8.
25. Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44:957-63.
26. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770-81.
27. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41:1569-82.
28. Machado M, Nassor N, Bajcar JM, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42:1195-207.
29. Brooks JM, Unni EJ, Klepser DG, et al. Factors affecting demand among older adults for medication therapy management services. Res Social Adm Pharm. 2008;4:309-19.
30. McCollum M, Nuffer W, Ellis SL, Turner CJ. Physician acceptance of pharmacotherapy recommendations made by pharmacy students in a rural pharmacy-based diabetes care and education clinic. Am J Pharm Educ. 2009;73(2):24.
31. DeName B, Divine H, Nicholas A, et al. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program. J Am Pharm Assoc. 2008;48:731-6.
32. Rhoads M, Thai A. Physician acceptance rate of pharmacist recommendations to reduce use of potentially inappropriate medications in the assisted living setting. Consult Pharm. 2003;18:241-7.
33. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use: a study of community-dwelling persons 65 years of age and older. Ann Intern Med. 1992;117:634-40.
34. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64.